Methylomic biomarkers of lithium response in bipolar disorder: a clinical utility study

Abstract Background Response to lithium (Li) is highly variable in bipolar disorders (BD). Despite decades of research, no clinical predictor(s) of response to Li prophylaxis have been consistently identified. Recently, we developed epigenetic Methylation Specific High-Resolution Melting (MS-HRM) as...

Full description

Bibliographic Details

Published in:	International Journal of Bipolar Disorders
Main Authors:	C. Marie-Claire, C. Courtin, F. Bellivier, S. Gard, M. Leboyer, J. Scott, B. Etain
Format:	Article
Language:	English
Published:	SpringerOpen 2023-04-01
Subjects:	DNA methylation Bipolar disorders Lithium MS-HRM Biomarker Transferability
Online Access:	https://doi.org/10.1186/s40345-023-00296-6